LGALS9 and neoplasm: Interestingly, with MF progression, the LGALS9-CD47 interaction switches places: in plaque MF, exhausted BTLA+ CD4+ T cells express CD47, and the tumor cells express ligand LGALS9, but in tumor MF, the opposite occurs.